Feedback Control Through cGMP-Dependent Protein Kinase Contributes to Differential Regulation and Compartmentation of cGMP in Rat Cardiac Myocytes

Rationale: We have shown recently that particulate (pGC) and soluble guanylyl (sGC) cyclases synthesize cGMP in different compartments in adult rat ventricular myocytes (ARVMs). Objective: We hypothesized that cGMP-dependent protein kinase (PKG) exerts a feedback control on cGMP concentration contributing to its intracellular compartmentation. Methods and Results: Global cGMP levels, cGMP-phosphodiesterase (PDE) and pGC enzymatic activities were determined in purified ARVMs. Subsarcolemmal cGMP signals were monitored in single cells by recording the cGMP-gated current (ICNG) in myocytes expressing the wild-type rat olfactory cyclic nucleotide-gated (CNG) channel. Whereas the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) (100 &mgr;mol/L) produced little effect on ICNG, the response increased 2-fold in the presence of the PKG inhibitors KT5823 (50 nmol/L) or DT-2 (2 &mgr;mol/L). The effect of KT5823 was abolished in the presence of the nonselective cyclic nucleotide PDE inhibitor 3-isobutyl-1-methylxantine (IBMX) (100 &mgr;mol/L) or the selective cGMP-PDE5 inhibitor sildenafil (100 nmol/L). PKG inhibition also potentiated the effect of SNAP on global cGMP levels and fully blocked the increase in cGMP-PDE5 activity. In contrast, PKG inhibition decreased by ≈50% the ICNG response to ANP (10 and 100 nmol/L), even in the presence of IBMX. Conversely, PKG activation increased the ICNG response to ANP and amplified the stimulatory effect of ANP on pGC activity. Conclusions: PKG activation in adult cardiomyocytes limits the accumulation of cGMP induced by NO donors via PDE5 stimulation but increases that induced by natriuretic peptides. These findings support the paradigm that cGMP is not uniformly distributed in the cytosol and identifies PKG as a key component in this process.

[1]  D. Kass,et al.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. , 2009, Pharmacology & therapeutics.

[2]  D. Cooper,et al.  Organization and Ca2+ regulation of adenylyl cyclases in cAMP microdomains. , 2007, Physiological reviews.

[3]  D. Kass,et al.  Compartmentalization of Cardiac &bgr;-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5 , 2007 .

[4]  J. Burnett,et al.  Natriuretic peptides and therapeutic applications , 2007, Heart Failure Reviews.

[5]  Franz Hofmann,et al.  cGMP-dependent Protein Kinase Type I Inhibits TAB1-p38 Mitogen-activated Protein Kinase Apoptosis Signaling in Cardiac Myocytes* , 2006, Journal of Biological Chemistry.

[6]  M. Silberbach,et al.  Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments , 2006, The Journal of general physiology.

[7]  D. Cooper,et al.  Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes , 2006, Circulation.

[8]  M. Zaccolo,et al.  Compartmentalized Phosphodiesterase-2 Activity Blunts &bgr;-Adrenergic Cardiac Inotropy via an NO/cGMP-Dependent Pathway , 2006, Circulation research.

[9]  D. Dickey,et al.  Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. , 2006, Endocrine reviews.

[10]  F. Hofmann,et al.  A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK‐I alpha does not regulate NPR‐A , 2006, Biochemistry.

[11]  D. Kass,et al.  Sildenafil Inhibits β-Adrenergic–Stimulated Cardiac Contractility in Humans , 2005 .

[12]  A. Papapetropoulos,et al.  Soluble guanylyl cyclase: more secrets revealed. , 2005, Cellular signalling.

[13]  H. Weiss,et al.  Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes , 2005, Experimental biology and medicine.

[14]  D. Kass,et al.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.

[15]  D. Cooper,et al.  Negative Feedback Exerted by cAMP-dependent Protein Kinase and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes , 2004, Journal of Biological Chemistry.

[16]  M. Zaccolo,et al.  cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.

[17]  Suhn Hee Kim,et al.  High and Low Gain Switches for Regulation of cAMP Efflux Concentration: Distinct Roles for Particulate GC- and Soluble GC-cGMP-PDE3 Signaling in Rabbit Atria , 2004, Circulation research.

[18]  H. Drexler,et al.  Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. , 2003, Cardiovascular research.

[19]  C. Roberts,et al.  Atrial Natriuretic Peptide Induces Natriuretic Peptide Receptor-cGMP-dependent Protein Kinase Interaction* , 2003, Journal of Biological Chemistry.

[20]  A. Friebe,et al.  Regulation of Nitric Oxide‐Sensitive Guanylyl Cyclase , 2003, Circulation research.

[21]  J. Kotera,et al.  cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5. , 2003, The Biochemical journal.

[22]  P. Cohen,et al.  The specificities of protein kinase inhibitors: an update. , 2003, The Biochemical journal.

[23]  F. Hofmann,et al.  Direct activation of PDE5 by cGMP , 2003, The Journal of cell biology.

[24]  J. Beavo,et al.  PDE5 is converted to an activated state upon cGMP binding to the GAF A domain , 2003, The EMBO journal.

[25]  J. Kotera,et al.  Phosphorylation of Isolated Human Phosphodiesterase-5 Regulatory Domain Induces an Apparent Conformational Change and Increases cGMP Binding Affinity* , 2002, The Journal of Biological Chemistry.

[26]  M. Conti,et al.  Dimerization of the Type 4 cAMP-specific Phosphodiesterases Is Mediated by the Upstream Conserved Regions (UCRs)* , 2002, The Journal of Biological Chemistry.

[27]  F. Hofmann,et al.  Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.

[28]  U. Kaupp,et al.  Cyclic nucleotide-gated ion channels. , 2002, Physiological reviews.

[29]  K. Murthy Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. , 2001, The Biochemical journal.

[30]  D. Kass,et al.  Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  Roger Y. Tsien,et al.  Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Fischmeister,et al.  G protein‐mediated inhibitory effect of a nitric oxide donor on the L‐type Ca2+ current in rat ventricular myocytes , 2001, The Journal of physiology.

[33]  M. S. Taylor,et al.  Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Rodríguez-Pascual,et al.  Nitric Oxide‐Sensitive Guanylyl Cyclase Activity Inhibition Through Cyclic GMP‐Dependent Dephosphorylation , 2000, Journal of neurochemistry.

[35]  U. Walter,et al.  KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells* , 2000, The Journal of Biological Chemistry.

[36]  J. Corbin,et al.  Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities. , 2000, European journal of biochemistry.

[37]  M. Kinoshita,et al.  Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. , 1999, American journal of physiology. Heart and circulatory physiology.

[38]  F. Lezoualc’h,et al.  Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L‐type Ca2+ current in rat ventricular myocytes , 1999, British journal of pharmacology.

[39]  K. Fujishige,et al.  Novel Alternative Splice Variants of cGMP-binding cGMP-specific Phosphodiesterase* , 1998, The Journal of Biological Chemistry.

[40]  T. Hunter,et al.  Phosphorylation of the Kinase Homology Domain Is Essential for Activation of the A-Type Natriuretic Peptide Receptor , 1998, Molecular and Cellular Biology.

[41]  L. Potter Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: dephosphorylation is a mechanism of desensitization. , 1998, Biochemistry.

[42]  C. Barnstable,et al.  Substituted cGMP analogs can act as selective agonists of the rod photoreceptor cGMP-gated cation channel , 1998, Journal of Molecular Neuroscience.

[43]  J. Corbin,et al.  ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. , 1998, American journal of physiology. Heart and circulatory physiology.

[44]  E. Degerman,et al.  Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)* , 1997, The Journal of Biological Chemistry.

[45]  T. Lincoln,et al.  Phosphorylation of the Inositol 1,4,5-Trisphosphate Receptor , 1996, The Journal of Biological Chemistry.

[46]  M. Conti,et al.  Phosphorylation and Activation of a cAMP-specific Phosphodiesterase by the cAMP-dependent Protein Kinase , 1995, The Journal of Biological Chemistry.

[47]  Michael Chinkers Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R Fischmeister,et al.  Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.

[49]  D. Garbers,et al.  Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. , 1992, The Journal of biological chemistry.

[50]  C. Lugnier,et al.  Cytosolic and membrane-bound cyclic nucleotide phosphodiesterases from guinea pig cardiac ventricles. , 1992, European journal of pharmacology.

[51]  R Fischmeister,et al.  Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[52]  F. Hofmann,et al.  Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. , 1988, The Biochemical journal.

[53]  R. Fischmeister,et al.  Atrial Natriuretic Factor Regulates the Calcium Current in Frog Isolated Cardiac Cells , 1988, Circulation research.

[54]  T. Lincoln,et al.  Purified cyclic GMP-dependent protein kinase catalyzes the phosphorylation of cardiac troponin inhibitory subunit (TN-1). , 1978, The Journal of biological chemistry.

[55]  D. Blumenthal,et al.  Phosphorylation of cardiac troponin by guanosine 3':5'-monophosphate-dependent protein kinase. , 1978, The Journal of biological chemistry.

[56]  M. M. Appleman,et al.  Multiple cyclic nucleotide phosphodiesterase activities from rat brain. , 1971, Biochemistry.

[57]  R. Lefkowitz,et al.  Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases , 2012 .

[58]  F. Hofmann,et al.  Function of cGMP-dependent protein kinases as revealed by gene deletion. , 2006, Physiological reviews.

[59]  Stepan Gambaryan,et al.  Fluorescent sensors for rapid monitoring of intracellular cGMP , 2005, Nature Methods.

[60]  D. Cooper,et al.  Negative Feedback Exerted by PKA and cAMP Phosphodiesterase on Subsarcolemmal cAMP Signals in Intact Cardiac Myocytes , 2004 .

[61]  Keith A. Jones,et al.  Differential effects of soluble and particulate guanylyl cyclase on Ca(2+) sensitivity in airway smooth muscle. , 2002, Journal of applied physiology.

[62]  P. Smits,et al.  Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. , 1993, Circulation.